Recent experience with fungaemia: change in species distribution and azole resistance (Q44253835)

1 December 2017

Recent experience with fungaemia: change in species distribution and azole resistance (English)

1 reference

1 December 2017

1 reference

1 reference

Arunaloke Chakrabarti

1

object named as

Arunaloke Chakrabarti

1 reference

1 December 2017

Shiv Sekhar Chatterjee

2

1 reference

1 December 2017

K L N Rao

3

1 reference

1 December 2017

M M Zameer

4

1 reference

1 December 2017

M R Shivaprakash

5

1 reference

1 December 2017

Sunit Singhi

6

1 reference

1 December 2017

Rajinder Singh

7

1 reference

1 December 2017

Shubhash Chandra Varma

8

1 reference

1 December 2017

1 January 2009

1 reference

Scandinavian Journal of Infectious Diseases

1 December 2017

1 reference

1 December 2017

41

1 reference

1 December 2017

275-284

1 reference

1 December 2017

4

1 reference

Epidemiology of invasive candidiasis: a persistent public health problem

1 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Candida glabrata fungemia: experience in a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Candida parapsilosis, an emerging fungal pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Invasive candidiasis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Nosocomial cluster of Candida guillermondii fungemia in surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Pichia anomala outbreak in a nursery: exogenous source?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Has antifungal susceptibility testing come of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Treatment of invasive candidal infections: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540902777105

10.1080/00365540902777105

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference